Mid-America Apartment Communities vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 77)

Mid-America Apartment Communities

LeaderReal Estate & Property Tech

Enterprise

Germantown TN Sunbelt multifamily REIT (NYSE: MAA) ~$2.2B FY2024 revenue; 100K+ apartments in 300+ communities, supply-cycle navigation, 30+ year dividend growth competing with Camden Property Trust and AvalonBay.

AI VisibilityBeta
Overall Score
B77
Category Rank
#289 of 290
AI Consensus
76%
Trend
stable
Per Platform
ChatGPT
78
Perplexity
71
Gemini
70

About

Mid-America Apartment Communities, Inc. (MAA) is a Germantown, Tennessee-based multifamily apartment REIT — publicly traded on the New York Stock Exchange (NYSE: MAA) as an S&P 500 Real Estate component — owning, developing, and managing apartment communities across Sunbelt and Southeast United States markets including Dallas-Fort Worth, Atlanta, Charlotte, Raleigh, Tampa, Orlando, Nashville, Phoenix, Denver, and Austin through approximately 2,500 employees. MAA owns approximately 300 multifamily communities with 100,000+ apartment homes, concentrated in the high-growth Sunbelt markets that experienced explosive population and employment migration during and after COVID-19 as remote and hybrid work enabled households to relocate from high-cost coastal metro areas (New York, Los Angeles, San Francisco, Washington DC) to lower-cost Sun Belt cities. In fiscal year 2024, MAA reported revenues of approximately $2.2 billion, with same-store revenue growth moderating to approximately 0.5-1% as elevated new apartment supply (100,000+ new Sunbelt apartments completed annually in Dallas, Austin, Atlanta, Nashville, and Charlotte from 2022-2024 construction pipeline) competed with MAA's existing portfolio for residents — creating the Sunbelt apartment supply headwind that affected MAA alongside all Sunbelt-focused apartment REITs. CEO Eric Bolton has led MAA through the supply cycle, maintaining 95%+ physical occupancy through rent concessions and lease renewal incentives rather than accepting vacancy, and positioning MAA for the post-supply-peak recovery (projected 2026-2027) when the 40% decline in new apartment construction starts from 2023-2024 reduces new completions in 2026 below population demand growth.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

77
Overall Score
90
#289
Category Rank
#9
76
AI Consensus
60
stable
Trend
stable
78
ChatGPT
99
71
Perplexity
99
70
Gemini
83
68
Claude
96
69
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.